Filter News
Area of Research
- Advanced Manufacturing (2)
- Biological Systems (1)
- Biology and Environment (12)
- Clean Energy (7)
- Computational Biology (1)
- Electricity and Smart Grid (1)
- Fusion and Fission (3)
- Isotopes (16)
- Materials (15)
- Materials for Computing (2)
- National Security (3)
- Neutron Science (33)
- Nuclear Science and Technology (7)
- Supercomputing (23)
News Type
News Topics
- (-) Advanced Reactors (8)
- (-) Biomedical (29)
- (-) Frontier (25)
- (-) Isotopes (28)
- (-) Microelectronics (3)
- (-) Neutron Science (49)
- 3-D Printing/Advanced Manufacturing (42)
- Artificial Intelligence (48)
- Big Data (27)
- Bioenergy (51)
- Biology (60)
- Biotechnology (12)
- Buildings (20)
- Chemical Sciences (27)
- Clean Water (14)
- Climate Change (51)
- Composites (8)
- Computer Science (87)
- Coronavirus (17)
- Critical Materials (5)
- Cybersecurity (14)
- Decarbonization (46)
- Education (1)
- Emergency (2)
- Energy Storage (30)
- Environment (105)
- Exascale Computing (27)
- Fossil Energy (4)
- Fusion (31)
- Grid (25)
- High-Performance Computing (45)
- Hydropower (5)
- ITER (2)
- Machine Learning (22)
- Materials (44)
- Materials Science (47)
- Mathematics (7)
- Mercury (7)
- Microscopy (20)
- Molten Salt (1)
- Nanotechnology (16)
- National Security (42)
- Net Zero (8)
- Nuclear Energy (56)
- Partnerships (19)
- Physics (30)
- Polymers (8)
- Quantum Computing (21)
- Quantum Science (31)
- Renewable Energy (1)
- Security (11)
- Simulation (32)
- Software (1)
- Space Exploration (12)
- Statistics (1)
- Summit (31)
- Sustainable Energy (47)
- Transformational Challenge Reactor (3)
- Transportation (27)
Media Contacts
When COVID-19 was declared a pandemic in March 2020, Oak Ridge National Laboratory’s Parans Paranthaman suddenly found himself working from home like millions of others.
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
A new method developed at Oak Ridge National Laboratory proves one effort’s trash is another’s valuable isotope. One of the byproducts of the lab’s national plutonium-238 production program is promethium-147, a rare isotope used in nuclear batteries and to measure the thickness of materials.
On Feb. 18, the world will be watching as NASA’s Perseverance rover makes its final descent into Jezero Crater on the surface of Mars. Mars 2020 is the first NASA mission that uses plutonium-238 produced at the Department of Energy’s Oak Ridge National Laboratory.
The ExOne Company, the global leader in industrial sand and metal 3D printers using binder jetting technology, announced it has reached a commercial license agreement with Oak Ridge National Laboratory to 3D print parts in aluminum-infiltrated boron carbide.
Marcel Demarteau is director of the Physics Division at the Department of Energy’s Oak Ridge National Laboratory. For topics from nuclear structure to astrophysics, he shapes ORNL’s physics research agenda.
Porter Bailey started and will end his 33-year career at ORNL in the same building: 7920 of the Radiochemical Engineering Development Center.
East Tennessee occupies a special place in nuclear history. In 1943, the world’s first continuously operating reactor began operating on land that would become ORNL.
A multi-institutional team, led by a group of investigators at Oak Ridge National Laboratory, has been studying various SARS-CoV-2 protein targets, including the virus’s main protease. The feat has earned the team a finalist nomination for the Association of Computing Machinery, or ACM, Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.